美国NIH与国防部达成协议 将部分预算用于医学对策研究

美国国立卫生研究院（NIH）与国防部达成协议，将以国家过敏症和传染病研究所（NIAID）的部分预算支持国防部的医学对策研究项目1。这一协议为期十年，资金来自NIAID 2026年国会拨款预算中的66亿美元1。

根据报道，国防部最初曾要求获得NIAID预算的约三分之一，但最终被告知可获得的额度约为预算的10%1。获得的资金将用于支持针对大流行流感、化学生物放射性核（CBRN）威胁以及新发传染病的医学对策先进开发研究1。协议的具体拨款额度尚未公布1。

The National Institutes of Health has reached an agreement with the Department of Defense to direct part of its budget toward defense medical countermeasure research, with the partnership set to last a decade 1. Under the arrangement, funding will come from the National Institute of Allergy and Infectious Diseases' $6.6 billion congressional appropriation for 2026, supporting advanced development of medical countermeasures against pandemic influenza, chemical-biological-radiological-nuclear threats, and emerging infectious diseases 1.

The Defense Department initially sought approximately one-third of the NIAID budget for the initiative but was ultimately informed the allocation would be roughly 10 percent 1. While the exact dollar amount transferred under the agreement has not been disclosed, the arrangement reflects a coordinated effort between the two agencies to address shared biosecurity priorities 1. The agreement was finalized approximately one month before the reports emerged 1.